Walgreens Boots Alliance, Inc. - Common Stock, par value $0.01 per share (WBA)

Historical Holders from Q1 2014 to Q1 2025

Symbol
WBA on Nasdaq
CUSIP
931427108
Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
863M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
534M
Holdings value
$4.98B
% of all portfolios
0.007%
Grand Portfolio weight change
+0%
Number of holders
862
Number of buys
369
Number of sells
-421
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Walgreens Boots Alliance, Inc. - Common Stock, par value $0.01 per share (WBA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Alliance Sante Participations S.A. 17.1% $1.63B 148M Stefano Pessina Mar 6, 2025
VANGUARD GROUP INC 10.04% $978M 86.8M The Vanguard Group Jan 31, 2025

Institutional Holders of Walgreens Boots Alliance, Inc. - Common Stock, par value $0.01 per share (WBA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 5.48M $61.2M -$19.3M $11.17 129
2024 Q4 534M $4.98B +$202M $9.33 862
2024 Q3 509M $4.56B -$162M $8.96 853
2024 Q2 517M $6.25B +$82.6M $12.10 907
2024 Q1 497M $10.8B -$79.2M $21.69 957
2023 Q4 504M $13.1B +$260M $26.11 1,028
2023 Q3 490M $10.9B -$318M $22.24 1,010
2023 Q2 489M $13.9B -$109M $28.49 1,109
2023 Q1 502M $17.4B +$45.8M $34.58 1,200
2022 Q4 501M $18.7B +$419M $37.36 1,241
2022 Q3 489M $15.4B -$279M $31.40 1,138
2022 Q2 481M $18.2B +$72.4M $37.90 1,251
2022 Q1 495M $22.2B +$142M $44.77 1,268
2021 Q4 475M $24.8B +$259M $52.16 1,326
2021 Q3 486M $22.9B +$108M $47.05 1,206
2021 Q2 477M $25.1B -$425M $52.61 1,247
2021 Q1 489M $26.8B +$654M $54.90 1,264
2020 Q4 477M $19B -$469M $39.88 1,129
2020 Q3 491M $17.6B -$104M $35.92 1,111
2020 Q2 490M $20.8B -$584M $42.39 1,189
2020 Q1 487M $22.3B -$874M $45.75 1,232
2019 Q4 508M $29.9B -$1.11B $58.96 1,305
2019 Q3 530M $29.3B -$291M $55.31 1,235
2019 Q2 535M $29.2B -$1.04B $54.67 1,275
2019 Q1 569M $36B -$1.54B $63.27 1,346
2018 Q4 592M $40.4B -$305M $68.33 1,380
2018 Q3 589M $42.9B -$663M $72.90 1,306
2018 Q2 610M $36.6B +$756M $60.01 1,279
2018 Q1 601M $39.3B +$120M $65.47 1,298
2017 Q4 604M $43.8B -$897M $72.62 1,305
2017 Q3 614M $47.4B -$2.96B $77.22 1,266
2017 Q2 653M $51.2B -$703M $78.31 1,278
2017 Q1 665M $55.2B +$4.92B $83.05 1,292
2016 Q4 659M $54.5B +$54M $82.76 1,289
2016 Q3 657M $52.9B -$219M $80.62 1,218
2016 Q2 653M $54.4B +$50M $83.27 1,245
2016 Q1 655M $55.2B +$177M $84.24 1,233
2015 Q4 656M $56B -$1.43B $85.15 1,224
2015 Q3 666M $55.3B +$527M $83.10 1,203
2015 Q2 637M $53.8B +$161M $84.44 1,185
2015 Q1 660M $55.9B +$3.51B $84.68 1,164
2014 Q4 616M $47B +$46.5B $76.20 1,028
2014 Q3 100K $6.6M +$3.52M $59.27 6
2014 Q2 3.7K $274K $0 $74.09 1
2014 Q1 3.7K $244K $0 $65.98 1